Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness  by Scuteri, Angelo et al.
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etabolic Syndrome Amplifies
he Age-Associated Increases
n Vascular Thickness and Stiffness
ngelo Scuteri, MD, PHD,*† Samer S. Najjar, MD,* Denis C. Muller, MS,* Reubin Andres, MD,*
idetaka Hougaku, MD,* E. Jeffrey Metter, MD,* Edward G. Lakatta, MD*
altimore, Maryland; and Rome, Italy
OBJECTIVES We sought to evaluate whether the clustering of multiple components of the metabolic
syndrome (MS) has a greater impact on these vascular parameters than individual components
of MS.
BACKGROUND Intima-media thickness (IMT) and vascular stiffness have been shown to be independent
predictors of adverse cardiovascular events. The MS is defined as the clustering of three or
more of the cardiovascular risk factors of dysglycemia, hypertension, dyslipidemia, and
obesity.
METHODS Carotid IMT and stiffness were derived via B-mode ultrasonography in 471 participants from
the Baltimore Longitudinal Study on Aging, who were without clinical cardiovascular disease
and not receiving antihypertensive therapy.
RESULTS The MS conferred a disproportionate increase in carotid IMT (16%, p  0.0001) and
stiffness (32%, p  0.0001), compared with control subjects. Multiple regression models,
which included age, gender, smoking, low-density lipoprotein, as well as each individual
component of MS as continuous variables, showed that MS was an independent determinant
of both IMT (p  0.002) and stiffness (p  0.012). The MS was associated with a greater
prevalence of subjects whose values were in the highest quartiles of IMT, stiffness, or both.
CONCLUSIONS Even after taking into account each individual component of MS, the clustering of at least
three of these components is independently associated with increased IMT and stiffness. This
suggests that the components of MS interact to synergistically impact vascular thickness and
stiffness. Future studies should examine whether the excess cardiovascular risk associated with
MS is partly mediated through the amplified alterations in these vascular properties. (J Am
Coll Cardiol 2004;43:1388–95) © 2004 by the American College of Cardiology Foundationi
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ahe metabolic syndrome (MS), also referred to as the
nsulin resistance syndrome, is defined as the clustering of
everal cardiovascular risk factors in an individual, including
mpaired glucose tolerance, hypertension, dyslipidemia, and
bdominal obesity (1–3). Epidemiologic studies have shown
hat MS is quite common, affecting 24% of the U.S.
opulation between the ages of 20 and 70 years (4). There
s increasing evidence that this syndrome is a predictor of
dverse cardiovascular events (4–7).
See page 1396
The independent association between vascular structure
nd function and the individual components of MS—
amely, hypertension (8 –12), high-density lipoprotein
HDL) cholesterol (13), triglycerides (8,14), waist circum-
erence (9), fasting glucose (14), and hemoglobin A1C
9)—has previously been reported.
From the *Laboratory of Cardiovascular Science, Laboratory of Clinical Investi-
ation, Gerontology Research Center, Intramural Research Program, National
nstitute on Aging, National Institutes of Health, Baltimore, Maryland; and †U.O.
eriatria, INRCA, Rome, Italy.
Manuscript received July 3, 2003; revised manuscript received September 6, 2003,pccepted October 20, 2003.Alterations in vascular structure and function, including
ncreased arterial wall thickness, as indexed by intima-media
hickness (IMT) and increased vascular wall stiffness, are
lso increasingly recognized as significant independent pre-
ictors of adverse cardiovascular outcomes (15–24).
We therefore undertook a cross-sectional study, using
ata from the Baltimore Longitudinal Study of Aging
BLSA), to examine the relationship between MS and large
rtery structure (thickness) and function (stiffness). We
ought to evaluate whether the clustering of multiple com-
onents of MS has a greater impact on these vascular
arameters than individual components of MS.
ETHODS
tudy population. The BLSA is a prospective study of
ommunity-dwelling volunteers, largely from the Balti-
ore/Washington area, conducted by the National Institute
n Aging since 1958. The BLSA participants are healthy
olunteers (age 21 to 96 years) who have agreed to return at
egular intervals to the Gerontology Research Center in
altimore, Maryland, for 2.5 days of medical, physiological,
nd psychological examinations (25). Carotid ultrasonogra-
hy was performed on a subset of the BLSA population
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April 21, 2004:1388–95 Metabolic Syndrome and Arterial Aginghosen in a non-systematic yet random fashion. Of those,
71 subjects were free of preexisting coronary artery disease
s defined by a history of angina pectoris, documented
yocardial infarction, or major Q waves on the resting
lectrocardiogram (Minnesota Code 1:1 or 1:2) (26).
ariables measured. BLOOD PRESSURE. Blood pressure
BP) determinations were performed in the morning, after a
ight breakfast, with subjects in the seated position, and after
quiet resting period of 5 min. Blood pressure was
easured in both arms with a mercury sphygmomanometer
sing an appropriately sized cuff. The BP values used in this
tudy are the average of the second and third measurements
n both the right and left arms. Values for systolic blood
ressure (SBP) and diastolic blood pressure (DBP) were
efined by Korotkoff phases I and V, respectively. Pulse
ressure was computed as PP  (SBP  DBP); and mean
P was computed as MBP  DBP  (PP/3).
A total of 134 subjects (94 men and 40 women) were
xcluded because of concurrent antihypertensive therapy at
he time of their first vascular measurement. These subjects
ere excluded because BP influences the values of the
ariables measured in the present study (8–12) and because
f the potential effects of specific antihypertensive drug
lasses on these parameters (27–31). However, secondary
nalyses were performed, including treated hypertensive
ubjects, to exclude a potential hypertension selection bias.
NTHROPOMETRY AND SMOKING STATUS. Height, weight,
nd waist circumference were determined for all partici-
ants. Body mass index was determined as kg/m2. Smoking
tatus was ascertained by a questionnaire that classified each
ubject as a non-smoker, former smoker, or current smoker.
or the purpose of the present study, “ever-smoker” status
former or current) was used.
LASMA LIPIDS AND FASTING BLOOD GLUCOSE. Blood
amples were drawn from the antecubital vein between 7
nd 8 AM after an overnight fast. Subjects were not allowed
o smoke, engage in significant physical activity, or take
edications before the sample was collected. Concentra-
ions of plasma triglycerides and total cholesterol were
etermined by an enzymatic method (Abott Laboratories
BA-200 ATC Biochromatic Analyzer, Irving, Texas).
Abbreviations and Acronyms
AGEPs  advanced glycation end products
BLSA  Baltimore Longitudinal Study of Aging
BP  blood pressure
CCA  common carotid artery
DBP  diastolic blood pressure
HDL  high-density lipoprotein
IMT  intima-media thickness
LDL  low-density lipoprotein
MS  metabolic syndrome
SBP  systolic blood pressurehe concentration of HDL cholesterol was determined by a textran sulfate-magnesium precipitation procedure (32).
ow-density lipoprotein (LDL) cholesterol concentrations
ere estimated by using the Friedewald formula. According
o the Third Report of the Expert Panel on Detection,
valuation, and Treatment of High Blood Cholesterol in
dults (Adult Treatment Panel III [ATP III]) (1), subjects
ith LDL160 mg/dl were classified as having high LDL.
The fasting plasma glucose concentration was measured
y the glucose oxidase method (Beckman Instruments, Inc.,
ullerton, California).
arotid ultrasonography. High-resolution B-mode ca-
otid ultrasonography was performed with a linear-array, 5-
o 10-MHz transducer (Ultramark 9 HDI, Advanced Tech-
ology Laboratories, Inc., Seattle, Washington). The sub-
ect lay in the supine position in a dark, quiet room. Blood
ressure was measured at 5-min intervals (Critikon
846SX/P, version 085, Dinamap, Critikon, Tampa, Flor-
da). The stabilized BP after 15 min from the onset of
esting was used for subsequent analyses. The right common
arotid artery (CCA) was examined with the head tilted
lightly upward in the mid-line position. The transducer
as manipulated so that the near and far walls of the CCA
ere parallel to the transducer footprint, and the lumen
iameter was maximized in the longitudinal plane. A region
.5 cm proximal to the carotid bifurcation was identified,
nd the IMT of the far wall was evaluated as the distance
etween the lumen-intima interface and the media-
dventitia interface. The IMT was measured on the frozen
rame of a suitable longitudinal image, with the image
agnified to achieve a higher resolution of detail. The IMT
easurement was obtained from five contiguous sites at
-mm intervals, and the average of the five measurements
as used for analyses. All measurements were performed by
single sonographer. The intrarater correlation between
epeated IMT measurements from 10 subjects was 0.96 (p
0.001), with similar averages for the two sets of readings
0.47  0.13 vs. 0.45  0.12 mm, p  NS) (33).
Stiffness of the CCA was evaluated by the stiffness index
no unit) that has been validated by Kawasaki et al. (34) and
irai et al. (35):
Stiffness index  lnSBP/DBP	/
d/D	
here 
d is the difference between the systolic and diastolic
ight CCA diameter, and D is the diastolic diameter. The
ntrarater correlation between repeated stiffness measure-
ents from 10 subjects was 0.96 (p  0.01), with similar
verages for the two sets of readings (6.37  2.59 vs.
.43  2.58, p  NS).
efinition of MS. The Third Report of the Expert Panel
n Detection, Evaluation, and Treatment of High Blood
holesterol in Adults (ATP III) (1) provided a working
efinition of MS, defined as an alteration in three or more
f the following five components: abdominal obesity, trig-
ycerides, HDL cholesterol, BP (systolic or diastolic), and
asting glucose. We employed this definition, which uses
he following cut-off values to define alterations: waist
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Metabolic Syndrome and Arterial Aging April 21, 2004:1388–95ircumference of 102 cm for men and 88 cm for women
or abdominal obesity, triglycerides 150 mg/dl, HDL
holesterol 40 mg/dl for men and 50 mg/dl for women,
P 130/85 mm Hg, and fasting glucose 110 mg/dl.
tatistical analysis. All analyses were performed using the
AS package (Cary, North Carolina). Data are presented as
he mean value  SD, unless otherwise specified. Differ-
nces in mean values for each of the measured variables in
ubjects with and without MS were compared by the t test
or continuous variables and by the chi-square test for
ategorical variables. A comparison of different age quartiles
ith or without MS was made by analysis of variance,
ollowed by Bonferroni’s test for all two-way comparisons,
r by chi-square analysis, as appropriate. Geometric mean
alues of vascular end points were calculated across catego-
ized features of MS by means of Proc GLM (SAS).
nalysis of co-variance (ANCOVA) was used to ascertain
nteractions between variables.
To evaluate the independent determinants of IMT and
tiffness, multiple regression models were constructed,
hich included age, gender, smoking, and each individual’s
isk factor component of MS (fasting glucose, SBP, DBP,
able 1. Anthropomorphic, Metabolic, and Vascular Profiles by
etabolic Syndrome Status
Control
Subjects
(n  376)
MS Patients
(n  95) p Value
ge (yrs) 57  17 62  15 0.01
ale gender (%) 39.9 52.6 0.05
urrent smoker (%) 6.9 7.4 NS
MI (kg/m2) 25.0  3.5 29.4  4.2 0.0001
aist circumference (cm) 83.9  11.2 98.3  9.8 0.0001
asting glucose (mg/dl) 94.5  13.6 110.7  32.4 0.0001
riglycerides (mg/dl) 83.0  43.7 168.3  83.0 0.0001
DL cholesterol (mg/dl) 51.8  13.9 39.4  10.0 0.0001
BP (mm Hg) 127  21 142  17 0.0001
BP (mm Hg) 78  10 87  10 0.0001
otal cholesterol (mg/dl) 176.6  34.7 188.3  37.8 0.01
DL cholesterol (mg/dl) 106.6  31.7 114.0  32.1 0.05
arotid IMT (mm) 0.51  0.14 0.59  0.17 0.0001
arotid stiffness index 6.49  2.90 8.55  4.99 0.0001
ata are presented as the mean value  SD or percentage of subjects.
BMI  body mass index; DBP  diastolic blood pressure; HDL  high-density
ipoprotein; IMT  intima–media thickness; LDL  low-density lipoprotein; MS 
etabolic syndrome; NS  not significant; SBP  systolic blood pressure.
able 2. Prevalence of Individual Components and Clusters of C
First Quartile
(n  118)
S
ge (yrs) 37  7
ltered waist circumference component (%) 15.4
ltered glucose component (%) 11.1
ltered triglyceride component (%) 9.4
ltered HDL component (%) 42.7
ltered BP component (%) 25.6
igh LDL cholesterol (%) 3.4
S† (%) 10.2
By chi-square analysis. †Alteration in three or more components. Data are presente
BP  blood pressure; other abbreviations as in Table 1.riglycerides, HDL cholesterol, and waist circumference as
ontinuous variables) as independent variables. A second set
f models was constructed, which also included LDL as a
o-variate. Both models yielded similar results; thus, only
he latter set is presented subsequently. Stepwise regression
nalysis was used to calculate the contribution of the
ignificant determinants of vascular indexes. To evaluate
hether MS was independently associated with vascular
tiffness and thickness, we ran the models again, after
dding in MS as a dummy variable. To confirm the
ignificance of MS, we constructed another set of models
hat included the individual components of MS (but with-
ut MS) as well as all of the possible interactions among
hese components. To illustrate the contribution of MS to
he values of IMT and stiffness, these values were calculated
ith the least-squares method after adjusting for: 1) age and
ender; 2) age, gender, and LDL; and 3) age, gender, LDL,
moking, and the individual components of MS. For each
djustment, the values were computed in the absence and in
he presence of MS in the model, and they were compared
y ANCOVA.
Logistic regression analysis was used to test whether MS
as associated with a greater prevalence of outliers in
arotid IMT, stiffness, or both after adjusting for age,
ender, and each component of MS. Outliers were defined
s values of IMT or stiffness that were in the highest
uartile.
ESULTS
ur study population consisted of 471 subjects (200 men
nd 271 women; mean age 59  16 years) free of clinical
vert cardiovascular disease at baseline. Table 1 shows the
linical characteristics of the study population. As expected,
he values of all the anthropometric, metabolic, and BP
ariables were higher in patients with MS than in control
ubjects. Patients with MS were, on average, five years older
p  0.01) and more likely to be men (52.6% vs. 39.9%, p
0.05) than those without MS. No difference in the
revalence of current smokers was observed between the two
roups. Carotid IMT was, on average, 16% higher, and
tiffness was, on average, 32% higher in MS patients than in
ontrols.
onents of the Metabolic Syndrome by Age Quartiles
Quartile
 117)
Third Quartile
(n  118)
Fourth Quartile
(n  118) p Value*
 2 64  4 79  6
24.1 24.3 21.8 NS
15.2 22.3 21.8 0.08
11.6 18.5 9.1 NS
41.1 35.9 38.2 NS
39.3 48.5 70.9 0.001
1.8 9.7 10.0 0.05
18.8 28.0 23.7 0.01
he mean value  SD or percentage of subjects.omp
econd
(n
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April 21, 2004:1388–95 Metabolic Syndrome and Arterial AgingThe prevalence of MS in this study population was
0.2%. Table 2 shows the prevalence of the individual
omponents of MS by quartiles of age, as well as the
revalence of MS itself, defined as the clustering of three or
ore of these components. The prevalence of hypertension
nd MS increased with advancing age group quartiles,
hereas a trend toward borderline statistical significance
as observed for altered glucose homeostasis. Of note,
lterations in HDL were more frequent than alterations in
DL in all age groups, which may be partly related to the
evels used as cut-off values. The prevalence of elevated
DL increased with advancing age groups.
Table 3. Multiple Regression Models Evaluati
Intima-Medial Thickness
MS Not Added to Model
Coefficient p Value
Age 0.0050 0.0001
Female gender 0.0343 0.001
LDL cholesterol 0.0005 0.01
Fasting glucose 0.0009 0.01
Model R2 0.406 0.0001
The metabolic syndrome was defined according to the Adult
smoking, LDL cholesterol, and each individual’s risk factor c
cholesterol, and waist circumference as continuous variable
significant after backward stepwise elimination are shown in
Abbreviations as in Table 1.
igure 1. Common carotid intima-media thickness (IMT) (A) and stiff-
ess (B) by age quartile and metabolic syndrome (MS) status. p  0.0001
or age effect; p  0.01 for MS effect; and p  NS for interaction. Open
ars  controls; solid bars  MS patients.Figure 1A shows that carotid IMT increased with ad-
ancing age quartiles in both MS patients and controls, and
hat in each age group, IMT was higher in MS patients than
n controls. Figure 1B shows that CCA stiffness increased
ith advancing age quartiles in controls, and that in each
roup, stiffness was higher in MS patients than in controls.
he interaction between age quartile and MS was not
tatistically significant, suggesting that the effects of MS on
CA thickness and stiffness do not significantly change
cross age groups.
ffects of MS on CCA thickness and stiffness. Multiple
egression models were constructed to evaluate the indepen-
ent contributions of factors on carotid IMT and stiffness.
first set of models included age, gender, smoking, LDL,
nd each individual’s component of MS, but excluded the
ariable of MS (i.e., clustering of MS components). As
hown in Table 3, age, male gender, LDL, and fasting
lood glucose were each independently associated with
MT (model R2  0.406, p  0.001). Age, fasting blood
lucose, SBP, and DBP (negative coefficient) were each
ndependently associated with stiffness (model R2  0.440,
 0.001). When the first set of models was run again after
dding MS as a dummy variable (second set), the variables
emained independently associated with IMT and stiffness,
espectively (Table 3). However, MS was also found to be
ndependently associated with both IMT (p  0.002) and
tiffness (p  0.01) (Tables 3 and 4), independent of the
ndividual components of MS, which were also in the
odel, and accounting for 1.3% and 1.4% of the variability
n IMT and stiffness, respectively.
Thus, the clustering of three or more of these compo-
ents (i.e., MS) was independently associated with IMT or
tiffness, even though several of the individual components
f MS were not, suggesting that the clustering of these
omponents interacted to exert synergistic effects on vascu-
ar structure and function. To explore this idea, an addi-
ional set of multiple regressions models were constructed
or both IMT and stiffness. These models included age,
ender, LDL, smoking, the individual components of MS,
nd interaction terms representing all of the possible inter-
ctions among these components as independent variables.
e Independent Determinants of Carotid
MS Added to Model
Coefficient p Value
Age 0.0050 0.0001
Female gender 0.0328 0.001
MS 0.0319 0.01
LDL cholesterol 0.0005 0.01
Fasting glucose 0.0007 0.05
Model R2 0.415 0.0001
ent Panel III criteria. All the models included age, gender,
ent of MS (fasting glucose, SBP, DBP, triglycerides, HDL
independent variables. Only those variables that remained
s 3 and 4.ng th
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s) as
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Metabolic Syndrome and Arterial Aging April 21, 2004:1388–95or IMT and stiffness, we found that several terms repre-
enting the interaction of three or more components of MS
ere independently associated with these vascular parame-
ers. This confirms that interactions among the individual
omponents of MS exert synergistic effects on IMT and
tiffness. Overall, the model R2 (0.48 for both) was modestly
ncreased by the addition of these interaction terms (R2 
.40 for IMT and R2  0.44 for stiffness in the absence of
he interaction terms). This is likely due to the dominant
ffect of age in accounting for the variance in IMT and
tiffness (35% for both).
To illustrate the contribution of MS to the values of IMT
nd stiffness, these values were calculated with the least-
quares method after adjusting for: 1) age and gender; 2)
ge, gender, and LDL; and 3) age, gender, LDL, smoking,
nd the individual components of MS (Table 5). For each
djustment, the values were calculated in the absence and in
he presence of MS in the model. By ANCOVA, the
ddition of MS to the models significantly increased the
alues of IMT and stiffness for all three adjustments. As
oted earlier, the magnitude of the change attributed to MS
as relatively small, because age was responsible for the
argest part of the total variance.
Log transformation of IMT yielded similar results. When
Table 4. Multiple Regression Models Evaluati
Carotid Stiffness
MS Not Added to Model
Coefficient p Value
Age 0.0658 0.0001
Fasting glucose 0.0447 0.01
SBP 0.0650 0.01
DBP 0.1115 0.001
Model R2 0.440 0.0001
The metabolic syndrome was defined according to the Adult
smoking, LDL cholesterol, and each individual’s risk factor c
cholesterol, and waist circumference as continuous variable
significant after backward stepwise elimination are shown in
Abbreviations as in Table 1.
able 5. Mean Adjusted Values of Carotid Intima–Media
hickness and Stiffness, Calculated by the Least Mean Squares
ethod, in the Absence or Presence of the Metabolic Syndrome
Adjusted for
Age and
Gender
Adjusted for
Age, Gender,
and LDL
Cholesterol
Multivariate
Model*
MT (mm)
No 0.522  0.006 0.522  0.006 0.525  0.007
Yes 0.561  0.012 0.559  0.012 0.562  0.016
p Value 0.005 0.009 0.04
tiffness index
No 6.61  0.17 6.60  0.16 6.51  0.15
Yes 7.83  0.34 7.59  0.33 7.70  0.36
p Value 0.002 0.008 0.005
The multivariate model included age, gender, LDL cholesterol, smoking, waist
ircumference, fasting blood glucose, HDL cholesterol, triglycerides, SBP, and DBP.
ata are presented as the mean value  SE.
Abbreviations as in Table 1. sreated and untreated hypertensive patients were combined,
he significance of the same predictors persisted on multiple
egression analyses, and the model R2 were reduced by only
%. These findings exclude a hypertension selection bias.
ffects of MS on combined CCA thickness and stiffness.
n unadjusted analyses, IMT and stiffness are significantly
p  0.001), albeit weakly (R2  0.11), correlated with each
ther. We investigated whether MS was independently
ssociated with simultaneous increases in the combined end
oint of carotid thickness and stiffness. Stiffness and IMT
ere divided into quartiles, and subjects were classified as
utliers for each or both parameters if their values fell in the
ighest quartile of the parameters. As shown in Figure 2,
he MS group included a significantly greater percentage of
ubjects classified as outliers for either IMT or stiffness,
ompared with controls. Furthermore, the MS group in-
luded a significantly greater percentage of subjects classi-
ed as outliers for both IMT and stiffness, compared with
ontrols. The increased risk of having excessive alterations
n one or both of these vascular parameters remained
ignificant even after adjusting for age, gender, and each
ndividual’s component of MS in a multivariable logistic
e Independent Determinants of
MS Added to Model
Coefficient p Value
Age 0.0635 0.0001
Fasting glucose 0.0348 0.01
SBP 0.0652 0.01
DBP 0.1226 0.001
MS 1.0660 0.01
Model R2 0.457 0.0001
ent Panel III criteria. All the models included age, gender,
ent of MS (fasting glucose, SBP, DBP, triglycerides, HDL
independent variables. Only those variables that remained
s 3 and 4.
igure 2. Ratio of the prevalence of outliers for carotid intima-media
hickness (IMT) and/or stiffness between metabolic syndrome patients
solid bars) and controls (open bars). Outliers for IMT or stiffness are
efined as subjects having values for IMT or stiffness that exceed the 75th
ercentile levels in the study population. p  0.001 across high quartileng th
Treatm
ompon
s) as
Tabletatus by analysis of variance.
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April 21, 2004:1388–95 Metabolic Syndrome and Arterial Agingodel (odds ratio 2.39, 95% confidence interval 1.09 to
.08; p  0.03).
ISCUSSION
he main findings of this study are that: 1) MS increases
arotid arterial thickness and stiffness across all age groups;
nd 2) MS exerts its effects on carotid structure and function
ndependent of its individual components and other cardio-
ascular risk factors.
To our knowledge, only one previous study has investi-
ated the relationship between MS and vascular stiffness. In
tudying a cohort of 180 non-diabetic, healthy, middle-aged
omen, van Popele et al. (36) found that carotid arterial
istensibility was associated with several variables of MS, as
ell as with clustering of variables of MS, even after
djusting for mean BP. Our study confirms these findings
nd extends them insofar as: 1) we used a different index of
tiffness that has been previously shown to be associated
ith insulin resistance in non-insulin-dependent diabetic
ubjects (37); 2) our study population included men and
omen; 3) was across a broad age range; and 4) showed that
he association between MS and vascular stiffness was
ignificant across all age groups. Furthermore, we found that
S, defined as the clustering of any three or more altered
omponents, was itself an independent predictor of stiffness.
mportantly, arterial stiffness is increasingly recognized as a
otent and independent predictor of adverse cardiovascular
utcomes (15–24).
The IMT increases with advancing age in humans (33)
nd in animal models of aging (38,39). In this study, we
ound that MS was associated with higher vascular wall
hickness, compared with controls, across all age groups. A
ew previous studies have evaluated the association between
S and IMT (40–42). In a cross-sectional population-
ased study in Sweden, Hedblad et al. (40) found that age-
nd gender-adjusted IMT was significantly higher in MS
atients than in controls. Hulthe et al. (41) studied clinically
ealthy 58-year-old men. They found that patients with MS
ad a significantly higher common carotid, carotid bulb, and
emoral IMT than did subjects without risk factors. On the
ther hand, they did not find any significant differences in
hese IMT variables between MS patients and those with
nly one risk factor. Of note, they used the World Health
rganization (2) definition of MS, which uses components
nd cut-off values for defining alterations in these compo-
ents that are somewhat different from those of the ATP
II.
A novel finding of our study is that MS conferred
ncreased odds of having both thicker and stiffer large
rteries. In fact, a significantly greater percentage of subjects
ith extremely high IMT and stiffness was observed in the
S group than in the control group.
There is increasing interest in the relevance of multiple
isk factors, as well as the existence of thresholds in the
elationships between the levels of known risk factors and ehe risk of disease (42–44). The presence of a dose-response
elation between the levels of known risk factors and the risk
f cardiovascular disease, whether measured by incident
ardiovascular event or “intermediate phenotypes” such as
ubclinical vascular disease, indicates that there is value in
odifying risk factors in people at high risk, irrespective of
he reason for the high risk and regardless of the level of the
isk factor.
otential mechanisms. It is conceivable that one of the
echanisms by which MS exerts its well-documented
eleterious effects is by adversely affecting the structural and
unctional properties of the vasculature (such as thickness
nd stiffness). Interestingly, MS was associated with a
igher prevalence of alterations in both vascular parameters.
lternatively, it is possible that a common pathogenic factor
ould underlie both the arterial structural changes and the
lterations in the components that comprise MS.
Circumferential wall stress and flow-mediated shear
tress are considered to be important determinants of
rterial wall structure and function during development and
heir remodeling during aging or in response to disease in
dults (45–49). Blood pressure and blood flow are major
eterminants of these mechanical stresses that act on the
rterial wall and lumen. Of note, we have previously
emonstrated that in the context of an increased circumfer-
ntial wall stress, specific alterations in carotid geometry
ere associated with differing levels of flow-mediated shear
tress and resulted in specific patterns of alterations in
arotid function (50).
Another potential mechanism by which MS can alter
arge-artery structure and function might be the glycation of
atrix proteins. Alterations in matrix proteins within the
essel wall can be derived from nonenzymatic cross-links
etween glucose (or other reducing sugars) and amino
roups that generate advanced glycation end products
AGEPs) (51,52). The AGEPs accumulate slowly on long-
ived proteins, such as collagen and elastin, and lead to
ncreased stiffening of both arteries and the heart (51). In
nimal models, decreasing these cross-links enhances vas-
ular and cardiac compliance (53–56). Of note, we recently
howed in a randomized, double-blinded, placebo-
ontrolled study that a novel medication that cleaves the
GEPs cross-links favorably impacts measures of vascular
tiffness in older human subjects (57).
tudy limitations. Certain limitations of this study should
e recognized, including its cross-sectional nature. Longi-
udinal observations are required in order to more fully
ddress the relationships and potential mechanistic links
etween MS and vascular structure and function. Further-
ore, the study population is relatively small, predomi-
antly Caucasian and well educated, which limits the
eneralizability of our findings, even though the prevalence
f MS in our study was similar to that observed by others
58). Future studies that include more racially and socio-
conomically diverse populations are needed to further
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ure and function.
An additional limitation is that the BP values used to
alculate the carotid stiffness index were measured over the
rachial artery, which tends to overestimate carotid pres-
ures due to central to peripheral BP amplification (59).
entral (carotid) BPs measured on the same visit as the
arotid Doppler studies were available for 26 subjects. As
nticipated, brachial SBP (116  14 mm Hg) exceeded
entral SBP (103  14 mm Hg). However, the correlation
etween central and brachial measurements of ln (SBP/
BP), the numerator of the stiffness index, was 0.92. These
ndings suggest a fixed difference in ln (SBP/DBP), which
hould lead to a fixed, systematic error in the stiffness index.
onclusions. Our analyses indicate that MS is indepen-
ently associated with increased thickness and stiffness of
he carotid artery. Because increased arterial stiffness and
hickness are well established as age-associated processes,
his suggests that MS can be perceived as accelerating
ascular aging. The excess alteration in carotid structure and
unction conferred by MS over and above the risk associated
ith abnormalities in each single component of this syn-
rome raises the prospect that integrated preventive or
herapeutic strategies that target multiple components of
S may yield synergistically improved outcomes, as com-
ared with those that are aimed at the individual
omponents.
Future studies should investigate the mechanistic links
etween MS and vascular aging, and whether strategies to
educe vascular stiffness or thickness can attenuate the
eleterious outcomes of MS.
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